Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer
Go back to Denali Therapeutics Appoints Katie Peng as Chief Commercial Officer| (NASDAQ: DNLI) | Delayed: 22.85 -0.41 (1.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.26 | 52 Week High | $ | |||
| Open | $23.33 | 52 Week Low | $ | |||
| Day High | $23.86 | P/E | N/A | |||
| Day Low | $22.53 | EPS | $ | |||
| Volume | 1,768,580 | |||||

